The call for general research abstracts and late-breaking abstracts is now closed. Thank you to all who have submitted their research!
SCM24 Abstract Timeline
Poster and E-Poster Guidelines
General submission abstract notifications have been distributed. Congratulations to all accepted authors!
All accepted research publications have the option to display a physical poster at SCM24, upload an e-poster to the online gallery, or both. Note that e-poster upload will not be available until closer to the meeting, and authors who choose to display a physical poster are required to print and bring their poster on-site at SCM. Please see the resources below for more information.
SCM24 Abstract Timeline
General research abstracts will be accepted from August 30 through November 30, 2023, 11:59pm PT.
Multiple research abstracts can be submitted by an individual. However, it is recommended to submit only one abstract per study. Submission of multiple abstracts on a single study may result in the rejection of one or more of the abstracts.
Abstract may be submitted in one of the below categories:
Late-breaking abstracts will be accepted from January 11 to February 1, 2024, 11:59pm PT.
Only results from major clinical trials or epidemiological studies will be considered for review.
NKF Embargo Policy
In compliance with the Securities and Exchange Commission's Regulation FD (Fair Disclosure), accepted abstracts are made available to the public on the NKF website and are published in AJKD, ACKD, JRN, or JNSW (dependent on discipline) in advance of the meeting. Thus, the first release of the abstracts is a public release. Coverage of additional research being presented at the NKF Spring Clinical Meetings is under embargo until 8am PT on May 15, 2024.
Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract. However, the NKF continues to require that information that goes beyond that contained within the abstract, e.g., discussion of the abstract done as part of a scientific presentation, is to be embargoed until the start of the Meetings. Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Journalists failing to abide by the embargo may have their press credentials revoked.
Important Dates & Deadlines